The Local Market Experts


AstraZeneca pays $64.5M for Amgen’s Longmont campus

Posted on: Oct 10 16

by: admin

LONGMONT – London-based pharmaceutical giant AstraZeneca PLC, which last year bought Amgen’s manufacturing facility in Boulder, has closed on the $64.5 million purchase of Amgen’s #Longmont plant.

The most recent buy includes 159 #Longmont CRE acres of vacant land just to the west of Amgen’s campus.

AstraZeneca officials announced the purchase Monday morning, though few details about were immediately available. AstraZeneca said in a news release that the Longmont site will be used to support the company’s existing operations in Boulder. The company added that the Longmont facility “will be staffed over time and according to business needs as the company’s pipeline matures and expansions are deemed necessary.”

“The Longmont facility adds to our expanding biologics commercial manufacturing capabilities as we prepare for our exciting future biologic medicines,” Darren Dasburg, AstraZeneca’s site director in Boulder, said in the release. “Integrating this site into our existing operations network will provide AstraZeneca and MedImmune, our global biologics research and development arm, with flexible biological manufacturing capacity to quickly bring new innovative treatments to patients.”

Amgen had originally listed its Longmont campus last year for $85 million.  Source: Biz West

Longmont Commercial Real Estate provides commercial real state sales & Leasing to established businesses, to start ups, to property owners and to investors in the greater Longmont Colorado area

Contacts

Longmont Commercial Real Estate Brokerage: Summit Commercial Brokers, 734 Arrowood St
Longmont CO 80503

Longmont Commercial Real Estate
734 Arrowood St
Longmont CO 80503
Phone: 303-746-1490
timconarro@gmail.com Copyright 2014